# Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT

> **NCT04822792** · — · UNKNOWN · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 11879 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** Multi-cancer early detection test

## Key facts

- **NCT ID:** NCT04822792
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-23
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 11879 (ESTIMATED)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04822792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04822792, "Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04822792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*